DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0600139 | Prostate carcinoma | FUT4 | 2526 | fucosyltransferase 4 | P22083 |
C0600139 | Prostate carcinoma | FUT3 | 2525 | fucosyltransferase 3 (Lewis blood group) | P21217 |
C0600139 | Prostate carcinoma | B3GAT1 | 27087 | beta-1,3-glucuronyltransferase 1 | Q9P2W7 |
C0600139 | Prostate carcinoma | ST6GALNAC3 | 256435 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 | Q8NDV1 |
C0600139 | Prostate carcinoma | FUT8 | 2530 | fucosyltransferase 8 | Q9BYC5 |
C0600139 | Prostate carcinoma | GCNT1 | 2650 | glucosaminyl (N-acetyl) transferase 1 | Q02742 |
C0600139 | Prostate carcinoma | GALNT3 | 2591 | polypeptide N-acetylgalactosaminyltransferase 3 | Q14435 |
C0600139 | Prostate carcinoma | ABO | 28 | ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | P16442 |
C0600139 | Prostate carcinoma | MGAT5 | 4249 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | Q09328 |
C0600139 | Prostate carcinoma | HAS3 | 3038 | hyaluronan synthase 3 | O00219 |
C0600139 | Prostate carcinoma | MGAT1 | 4245 | alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | P26572 |
C0600139 | Prostate carcinoma | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C0600139 | Prostate carcinoma | ST6GAL1 | 6480 | ST6 beta-galactoside alpha-2,6-sialyltransferase 1 | P15907 |
C0600139 | Prostate carcinoma | C1GALT1 | 56913 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 | Q9NS00 |
C0600139 | Prostate carcinoma | ST3GAL1 | 6482 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Q11201 |
C0600139 | Prostate carcinoma | GAL3ST2 | 64090 | galactose-3-O-sulfotransferase 2 | Q9H3Q3 |
C0600139 | Prostate carcinoma | ST8SIA4 | 7903 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | Q92187 |
C0600139 | Prostate carcinoma | ST3GAL3 | 6487 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | Q11203 |
C0600139 | Prostate carcinoma | SLC35B4 | 84912 | solute carrier family 35 member B4 | Q969S0 |
C0600139 | Prostate carcinoma | DDOST | 1650 | dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit | P39656 |
C0600139 | Prostate carcinoma | GALNS | 2588 | galactosamine (N-acetyl)-6-sulfatase | P34059 |
C0600139 | Prostate carcinoma | GLB1 | 2720 | galactosidase beta 1 | P16278 |
C0600139 | Prostate carcinoma | GUSB | 2990 | glucuronidase beta | P08236 |
C0600139 | Prostate carcinoma | LIPA | 3988 | lipase A, lysosomal acid type | P38571 |
C0600139 | Prostate carcinoma | ASAH1 | 427 | N-acylsphingosine amidohydrolase 1 | Q13510 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024